ACTG — Acacia Research Balance Sheet
0.000.00%
- $336.59m
- $104.93m
- $122.31m
- 69
- 74
- 59
- 76
Annual balance sheet for Acacia Research, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 451 | 707 | 386 | 440 | 334 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.506 | 9.52 | 8.23 | 80.6 | 26.9 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 458 | 731 | 428 | 555 | 420 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.22 | 6.21 | 5.54 | 29.3 | 225 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 511 | 799 | 483 | 634 | 756 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 125 | 200 | 87.2 | 27.6 | 47.2 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 223 | 365 | 205 | 65.3 | 242 |
| Redeemable Preferred Stock | |||||
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 288 | 434 | 278 | 568 | 515 |
| Total Liabilities & Shareholders' Equity | 511 | 799 | 483 | 634 | 756 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |